Özkaya Esen
Istanbul Üniversitesi Istanbul Tıp Fakültesi, Deri ve Zührevi Hastalıklar Anabilim Dalı, 34093 Istanbul, Turkey.
Cutis. 2013 Sep;92(3):121-4.
Multiple drug allergy (MDA) is characterized by hypersensitivity to 2 or more chemically unrelated drugs. Multiple drug allergy from simultaneous use of antituberculosis drugs is a rare phenomenon that mainly presents as an urticarial or maculopapular eruption. This case report describes a 58-year-old man who developed a generalized eczematous eruption during the sixth week of oral therapy with 4 antituberculosis drugs-isoniazid, ethambutol, rifampicin, and morphazinamide-for treatment of suspected pleural tuberculosis. The eruption resolved after treatment with systemic corticosteroids and cessation of isoniazid and ethambutol. During a lesion-free period 6 months after cessation of the corticosteroids, patch testing with serial dilutions of isoniazid and ethambutol revealed positive reactions; irritant patch test reactions were excluded by testing with graded concentrations of each drug. The patient avoided the causative drugs and reported no new eruptions at 1-year follow-up. It is important for dermatologists to consider the value of patch testing in determining the causative drugs in suspected cases of eczematous-type MDA.
药物过敏(MDA)的特征是对两种或更多种化学结构不相关的药物过敏。同时使用抗结核药物引起的药物过敏是一种罕见现象,主要表现为荨麻疹或斑丘疹。本病例报告描述了一名58岁男性,在使用异烟肼、乙胺丁醇、利福平和平胺硝唑4种抗结核药物口服治疗疑似胸膜结核的第6周出现全身性湿疹样皮疹。在使用全身性糖皮质激素治疗并停用异烟肼和乙胺丁醇后,皮疹消退。在停用糖皮质激素6个月后的无皮损期,对异烟肼和乙胺丁醇进行系列稀释斑贴试验显示阳性反应;通过对每种药物进行梯度浓度测试排除了刺激性斑贴试验反应。患者避免使用致病药物,在1年随访时未报告新的皮疹。皮肤科医生在疑似湿疹型MDA病例中确定致病药物时考虑斑贴试验的价值很重要。